---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-022771"
form_type: "8-K"
ticker: "GNPX"
cik: "0001595248"
company_name: "Genprex, Inc."
filed_at: "2021-09-28T23:59:59+00:00"
generated_at: "2026-06-29T01:00:22.006615+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Genprex appoints Dr. Berger as CMO and Dr. Kumar as CMTO, effective Sept 27, 2021

## Summary
- Mark S. Berger, M.D. named Chief Medical Officer; annual base salary $450,000 plus up to 40% bonus and 550k stock option at $2.85/sh.
- Hemant Kumar, Ph.D. named Chief Manufacturing and Technology Officer; base salary $325,000 plus up to 40% bonus and 400k stock option at $2.85/sh.
- Both roles are newly created; Berger and Kumar report to CEO Rodney Varner.
- Berger previously CMO at Actinium Pharmaceuticals; Kumar most recently VP at Arcturus Therapeutics.

## SEC filing metadata
- accession: 0001437749-21-022771
- form_type: 8-K
- ticker: GNPX
- cik: 0001595248
- company_name: Genprex, Inc.
- filed_at: 2021-09-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595248/000143774921022771/0001437749-21-022771-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595248/000143774921022771/gnpx20210928_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-022771
- JSON: https://secwatch.observer/filing/0001437749-21-022771.json
- Plain text: https://secwatch.observer/filing/0001437749-21-022771.txt

## Key facts
- Executive change
  Mark S. Berger, M.D. was appointed as Chief Medical Officer at Genprex, Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: Effective as of September 27, 2021, the Board of Directors (the "Board") of Genprex, Inc. ("Genprex") appointed Mark S. Berger, M.D. as Chief Medical Officer of Genprex.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595248/000143774921022771/0001437749-21-022771-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.